These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 19481693

  • 1. Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation.
    Dong Y, Ng WK, Shen S, Kim S, Tan RB.
    Int J Pharm; 2009 Jun 22; 375(1-2):84-8. PubMed ID: 19481693
    [Abstract] [Full Text] [Related]

  • 2. A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs.
    Dong Y, Ng WK, Hu J, Shen S, Tan RB.
    Int J Pharm; 2010 Feb 15; 386(1-2):256-61. PubMed ID: 19922777
    [Abstract] [Full Text] [Related]

  • 3. Controlled antisolvent precipitation of spironolactone nanoparticles by impingement mixing.
    Dong Y, Ng WK, Shen S, Kim S, Tan RB.
    Int J Pharm; 2011 May 30; 410(1-2):175-9. PubMed ID: 21397674
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y, Sun C, Hao Y, Jiang T, Zheng L, Wang S.
    J Pharm Pharm Sci; 2010 May 30; 13(4):589-606. PubMed ID: 21486533
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation.
    Zhao X, Wang W, Zu Y, Zhang Y, Li Y, Sun W, Shan C, Ge Y.
    Drug Deliv; 2014 Sep 30; 21(6):467-79. PubMed ID: 24479653
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Analysis of nucleation kinetics of poorly water-soluble drugs in presence of ultrasound and hydroxypropyl methyl cellulose during antisolvent precipitation.
    Dalvi SV, Dave RN.
    Int J Pharm; 2010 Mar 15; 387(1-2):172-9. PubMed ID: 20026199
    [Abstract] [Full Text] [Related]

  • 9. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
    Hu J, Ng WK, Dong Y, Shen S, Tan RB.
    Int J Pharm; 2011 Feb 14; 404(1-2):198-204. PubMed ID: 21056643
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Adsorption of pharmaceutical excipients onto microcrystals of siramesine hydrochloride: effects on physicochemical properties.
    Zimmermann A, Millqvist-Fureby A, Elema MR, Hansen T, Müllertz A, Hovgaard L.
    Eur J Pharm Biopharm; 2009 Jan 14; 71(1):109-16. PubMed ID: 18619536
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nanoamorphous drug products - Design and development.
    Jog R, Burgess DJ.
    Int J Pharm; 2018 Dec 20; 553(1-2):238-260. PubMed ID: 30359685
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Solubilization of the poorly water soluble drug, telmisartan, using supercritical anti-solvent (SAS) process.
    Park J, Cho W, Cha KH, Ahn J, Han K, Hwang SJ.
    Int J Pharm; 2013 Jan 30; 441(1-2):50-5. PubMed ID: 23262425
    [Abstract] [Full Text] [Related]

  • 17. Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization.
    Matteucci ME, Hotze MA, Johnston KP, Williams RO.
    Langmuir; 2006 Oct 10; 22(21):8951-9. PubMed ID: 17014140
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.